LUNG vs MNST · rev $43.3M vs P/E 46, rev $4.89B
Pulmonx Corp (LUNG) versus Monster Beverage Corp (MNST) — a side-by-side from cached financials, not a winner call.
Pulmonx Corp (LUNG) is a medical devices company listed on US.
Monster Beverage Corp (MNST) is a beverages - non-alcoholic company listed on US.
Latest reported LUNG revenue for 2026-06-30 was $43.3M. Net income was -$23.7M. LUNG currently screens at market cap $111.9M.
Latest reported MNST revenue for 2026-06-30 was $4.89B. Net income was $1.15B. MNST currently screens at market cap $94.01B and trailing P/E 46.4.
LUNG currently screens at market cap $111.9M. MNST currently screens at market cap $94.01B and trailing P/E 46.4.
Not investment advice. Open the LUNG and MNST stock pages for the full models.
Not investment advice.